Logo
    Search

    #143 - John Ioannidis, M.D., D.Sc.: Why most biomedical research is flawed, and how to improve it

    enJanuary 04, 2021

    Podcast Summary

    • John Ayanidis: A Polymath Expert in Meta-ResearchJohn Ayanidis, a Stanford professor with a background in mathematics, medicine, and epidemiology, challenges the accuracy of most published research in biomedical field using mathematics and advocates for rigorous evaluation of scientific findings to improve human lives

      John Ayanidis, a polymath and Stanford University professor, is a leading expert in meta-research, which involves studying the credibility of scientific research. He has a unique background in mathematics, medicine, and epidemiology, and his work includes a groundbreaking paper that challenges the accuracy of most published research in the biomedical field. Ayanidis is passionate about using mathematics to transform our approach to scientific questions and improve human lives through medicine. He grew up in Greece with a love for mathematics and later pursued a career in medicine due to its potential to save lives. Despite his diverse interests, he sees medicine and mathematics as complementary fields. Throughout the podcast episode, Ayanidis shares insights on his research and the importance of rigorously evaluating scientific findings.

    • The Importance of Clinical Exposure and Research Background in Reliable Clinical ResearchMost clinical research is unreliable due to biases and poor methodology, emphasizing the need for rigorous scientific methods and evidence-based medicine.

      The reliability of clinical research depends on rigorous scientific methods and quantitative tools. The speaker, a physician-scientist, emphasized the importance of both clinical exposure and research background. He grew up with parents who were physician-scientists and was exposed to their clinical work and research. He completed medical school in Greece and furthered his training in the US, including at Harvard and Tufts. During his training, he was influenced by several individuals, including a professor of epidemiology in Greece and physician-scientists at Harvard and Tufts. These mentors instilled in him the importance of evidence-based medicine, which he encountered in the early 1990s. He was particularly inspired by Tom Chalmers, who was a pioneer in evidence-based medicine and the first to design a randomized trial and perform meta-analyses. The speaker's work came onto the interlocutor's radar in 2005 with a provocative paper in the open-source journal, PLoS Medicine, titled "Why Most Published Clinical Research is Untrue: A Systematic Review of Systematic Reviews." The paper argued that most clinical research is unreliable due to various biases and poor methodology. This call for greater rigor in clinical research continues to be a significant issue in medical science.

    • Assessing the reliability of scientific researchA mathematical model was proposed to calculate the probability that a statistically significant result is not a red herring, considering the discovery potential, study power, and presence of bias in a field.

      The reliability of scientific research is a significant concern due to the high percentage of published papers that go uncited and the prevalence of biases and unreliable results. A mathematical model was proposed to help assess the likelihood of a non-null effect in research, taking into account the field's discovery potential, study power, and the presence of bias. The model aims to calculate the probability that a statistically significant result is not a red herring, considering the prior chances of discoveries in various fields and the power of the studies to detect true effects. Additionally, the model considers the impact of bias, which can make null results appear significant, and the interplay of biases among the vast scientific workforce. This framework provides a valuable tool for evaluating the credibility of research findings and addressing the challenges of ensuring reliable evidence in scientific decision-making.

    • Statistical significance vs Clinical significanceWhile statistical significance refers to the likelihood of observing a result, clinical significance determines its practical impact. The default threshold for statistical significance is 0.05, but it may not indicate clinically significant findings. Understanding both is crucial for accurate research interpretation.

      The concept of statistical significance, often denoted by a p-value, is not the same as clinical significance. While statistical significance refers to the likelihood of observing a result as extreme as the one obtained given an infinite number of trials, clinical significance refers to the practical impact or importance of a finding. In most research fields, including medicine, the default threshold for statistical significance is 0.05, but there is a growing consensus that this threshold should be more stringent. However, a low p-value does not necessarily indicate a clinically significant finding, as it could be due to bias or other factors. The misconceptions around statistical significance have led to what some call the "statistics wars," with some advocating for abandoning the term altogether and focusing solely on effect sizes and uncertainty. Despite this, it is essential to maintain a nuanced understanding of both statistical and clinical significance to interpret research findings accurately.

    • Underpowering studies can lead to false positives and exaggerated resultsEnsure studies are adequately powered to minimize errors and maximize clinically significant findings

      While statistical significance and pre-specified hypotheses are important in some types of research, underpowering studies can lead to false positives and exaggerated results. The scientific community has been operating in underpowered environments due to limited resources, competition, and incentives to publish seemingly statistically significant results. This can result in a high number of false positives or exaggerated estimates of the magnitude of signals. On the other hand, overpowering studies can provide more accurate results, but they also come with their own challenges. It is crucial to find a balance and ensure that studies are adequately powered to minimize errors and maximize clinically significant findings.

    • Addressing challenges in nutritional epidemiologyNutritional epidemiology should adopt large-scale studies, collaboration, and transparency from genetics research to improve accuracy and reduce bias.

      While the era of big data and genetics research has brought about significant advancements, it also presents new challenges such as measuring bias and ensuring statistical significance. This issue is particularly prevalent in genetics research, which has seen a cultural shift towards transparency, large-scale studies, and collaboration. However, in fields like nutritional epidemiology, which relies on less accurate measurement tools and is fraught with strong opinions and beliefs, self-policing and cultural shifts have been slower to occur. The lack of accurate measurement tools and the presence of strong opinions in nutritional epidemiology contribute to the propagation of subpar information. To address these challenges, nutritional epidemiology should adopt the genetics approach of large-scale studies, collaboration, and transparency to maximize power and standardization.

    • Genetics and Nutrition Research Progress at Different PacesGenetics research advances faster with objective methods, while nutrition research faces criticism for sub-optimal methods and fraudulent studies. Approach nutrition research with caution, but there's solid evidence for many observational associations.

      While both genetics and nutrition research aim to improve our understanding of health and wellbeing, they have progressed at different paces due to various scientific, cultural, and methodological reasons. Genetics research has advanced faster and become more objective, while nutrition research has been criticized for its sub-optimal methods and the prevalence of poorly done or even fraudulent studies. Austin Bradford Hill, a pioneer in epidemiology, would likely have been cautious about the claims made based on observational associations in nutrition research, recognizing that none of his criteria are bulletproof. Despite the challenges, there is solid evidence for many observational associations in nutrition, such as the link between tobacco use and lung cancer. However, it's essential to approach the field with caution and continue working towards more rigorous research practices.

    • Strong and consistent odd ratios between smoking and health outcomesSmoking's impact on health outcomes, such as cancer and cardiovascular disease, is significant and consistent, with odds ratios often in the double digits, contrasting typical odds ratios in epidemiology.

      The relationship between smoking and various health outcomes, particularly cancer and cardiovascular disease, is characterized by strong and consistent odd ratios, often in the range of 10, 20, and 30. This is in stark contrast to what is commonly seen in epidemiology today, where odds ratios of 1.01 are more typical. The strength and consistency of the smoking-health outcome relationship are so impressive that other criteria, such as specificity, may not be as important. However, in the field of nutritional epidemiology, where signals are often weaker and less consistent, other criteria may play a more significant role. For example, experimental plausibility can be important, and large randomized trials have been conducted to test nutritional hypotheses. While some of these trials have shown benefits, many have not, leading some to question the validity of observational signals in nutrition. Ultimately, a balanced approach is necessary, recognizing that both observational and experimental evidence have their strengths and limitations.

    • Understanding dietary efficacy in real life vs. controlled studiesWhile controlled studies provide insights, real-world effectiveness matters most for diet and nutrition research.

      While it's important to understand what diet may be theoretically better, what truly matters is its effectiveness in real-world scenarios with real people. However, there's still a role for studying dietary efficacy under controlled circumstances, such as in clinical trials or Mendelian randomization studies. These approaches can provide valuable insights, but it's crucial to interpret the results cautiously due to the limitations of these methods. Additionally, advancements in data analysis, like exposure-wide association studies, can help us better understand the complex relationships between various nutrients and health outcomes. Ultimately, a more comprehensive and transparent approach to studying diet and nutrition is necessary to make meaningful progress in this field. John's 2005 paper on the frequency of valid scientific publications and his 2012 paper on the systematic cookbook review serve as reminders of the challenges and importance of this ongoing research.

    • Study on common ingredients and cancer risk sparks controversyResearcher calls for better data, evidence, and unbiased synthesis in nutritional epidemiology, acknowledges challenges in overcoming deeply held beliefs and institutional biases.

      The study selected 50 common ingredients from a cookbook at random and found that nearly all of them had published studies associating them with cancer risk. However, the paper's reception in the nutritional epidemiology community was mixed, with some criticisms coming from concerns about transparency and potential cherry-picking of data. The researcher emphasized the importance of generating better data, evidence, and synthesis in a more unbiased way, regardless of personal beliefs or opinions. They also acknowledged the challenge of overcoming deeply held beliefs in scientific fields. Despite disagreements, the researcher expressed a willingness to see whatever result emerges from a more rigorous and unbiased approach. The researcher also highlighted the importance of large-scale meta-analyses but cautioned against cherry-picking studies based on preconceived beliefs. Institutional biases were also mentioned as a potential issue. Overall, the researcher's goal was to improve the scientific process and generate more reliable evidence in the field of nutritional epidemiology.

    • Impact of Beliefs on Scientific ResearchBeliefs and conflicts can influence research findings, leading to non-reproducible results or incorrect conclusions. Transparency and self-awareness are crucial to minimizing their impact.

      While human nature and beliefs play a role in scientific research, it's crucial to minimize the chances of fooling ourselves and maintaining transparency about potential conflicts and beliefs. The DB Cooper case serves as an example of how deeply held beliefs can lead individuals to believe they've identified the culprit, even when they're likely wrong. In science, this can lead to non-reproducible results or incorrect conclusions. Research practices are substandard in many scientific fields, with surveys suggesting that while fraud may be uncommon, suboptimal practices are more prevalent. Transparency and self-awareness are essential to minimizing the impact of beliefs and conflicts on research findings.

    • Addressing questionable research practicesContinuous training, community awareness, and promoting better methods and inference tools are essential to improve research standards and create an environment that supports high-quality, innovative research.

      While scientific misconduct may not be common, questionable research practices are prevalent and require attention. Addressing these issues involves continuous training, community awareness, and the promotion of better methods and inference tools. It's essential to remember that the scientific community is vast and diverse, with varying levels of expertise and familiarity with best practices. Rather than cutting back on research, the focus should be on improving research standards and creating an environment that supports and incentivizes high-quality, innovative research. This approach will ultimately lead to a more reliable and trustworthy scientific literature.

    • Balancing Industry, Government, and Philanthropy in Scientific ResearchIndustry prioritizes financial returns, limiting their funding for high-risk research. Government funding is essential but often subject to legislative processes and lacks scientific expertise. Philanthropy plays a crucial role in supporting high-risk research, and public funding should focus on testing benefits and harms.

      The funding landscape for scientific research is complex and requires a balance between industry, government, and philanthropy. Industry prioritizes financial returns, limiting their risk appetite for discovery. Government funding, while essential, is often subject to legislative processes and lacks scientific expertise, making it a suboptimal place for high-risk research. Philanthropy, with no strings attached funding, plays a crucial role in supporting high-risk research that might not be funded otherwise. However, public funding is also necessary and should be realigned to focus on testing the benefits and harms of products, rather than financing their development. The communication of scientific research to the public is also crucial, with scientists needing to take a more active role in explaining the high-risk nature of research and the importance of funding it. The success stories of high-risk projects like the Manhattan Project and NASA demonstrate that the public is willing to support such endeavors when effectively communicated.

    • Defending the honesty of science in public communicationScientists must be transparent and avoid exaggeration when communicating with the public, using lobbying tactics or scientific methods. Complex nutritional research highlights the need for better training and methods to prevent misleading results, and the consequences of inaccurate information can be significant.

      As scientists, it's essential for us to defend the honesty and principles of science when communicating with the public. However, the current landscape of media and agendas can make it challenging to be heard above the noise. Two paths forward are using lobbying tactics or sticking to scientific methods. While both have their merits, it's crucial to avoid exaggeration and maintain transparency. The complexity of nutritional epidemiology research highlights the need for better methods and training to prevent misleading results. The consequences of inaccurate information can be significant, and it's our responsibility as scientists to ensure the public receives reliable information. By fostering humility and understanding, we can bridge the gap between scientific knowledge and public awareness.

    • Compromised randomization process in Predimed studyThe importance of rigorously executing clinical trials to maintain their credibility and ensure valid results, even with the high cost and duration involved.

      The integrity of a clinical trial is paramount. The Predimed study, which compared a low-fat diet to two Mediterranean diets (one with olive oil and the other with nuts), showed promising results initially. However, it was later discovered that the randomization process had been compromised, leading to a partly randomized and partly observational trial. This significant flaw casts doubt on the credibility of the trial's results, despite its initial clinically relevant and statistically significant findings. The importance of meticulously executing clinical trials, even with the high cost and duration involved, cannot be overstated. This example serves as a reminder of the potential consequences of research that falls short of the gold standard of randomized controlled trials.

    • Variability in research expertise leads to potential bias and inaccuracies in multi-center clinical trialsThe reliability of data in multi-center clinical trials can be compromised due to varying levels of methodological training and expertise among researchers, potentially leading to bias and inaccuracies.

      The reliability of data in multi-center clinical trials, particularly those funded by industry, can be compromised due to varying levels of methodological training and expertise among researchers involved. This can lead to bias and inaccuracies, even if the data isn't outright fraudulent. The 2020 COVID-19 pandemic brought forth the importance of this issue when studies on seroprevalence, such as those in Santa Clara and LA County, revealed much higher rates of infection than confirmed cases, challenging prior beliefs about the virus's mortality rate and spread. These findings were met with both excitement and controversy due to the politically charged environment surrounding the pandemic.

    • Controversy over COVID-19 infection fatality rate studyA study on COVID-19 infection fatality rate faced criticism during the pandemic's early stages. Criticism led to improvements and the study's accuracy was later validated. Importance of separating science from politics and basing findings on data was emphasized.

      During the early stages of the COVID-19 pandemic, there was significant controversy surrounding a study estimating the infection fatality rate. The study, which was later validated by subsequent research, showed that the virus was rapidly and widely spreading, and the infection fatality rate varied greatly depending on the population. The author expressed gratitude for the criticism, which helped improve the paper, and acknowledged that some of the backlash was due to the toxic political environment at the time. He emphasized the importance of keeping science separate from politics and urged that findings be based on data and scientific evidence, rather than political ideology. Despite some misconceptions and personal attacks, the study ultimately proved to be accurate and influential in understanding the nature of the virus.

    • Attacks on Scientists During Crises: Consequences and SolutionsProtecting scientists and promoting a culture of tolerance towards scientific findings is crucial during crises to prevent silencing and hindrance of scientific progress.

      The attacks on scientists and their research during times of crisis, such as the ongoing COVID-19 pandemic, can have devastating consequences not only for the individuals involved but also for the scientific community as a whole. These attacks, which can come from various political ideologies, can silence scientists and hinder the progress of science. It is crucial that we protect scientists and allow them to do their work without fear of smear campaigns or threats to themselves and their families. The scientific process involves making mistakes, correcting them, and updating beliefs with new information. In politics, however, changing one's mind is often seen as a weakness. It is essential to promote a culture of tolerance and understanding towards scientific findings, regardless of political affiliations. The recent surge in public interest in science due to the pandemic presents an opportunity to communicate more science and improve science education, but it also poses challenges in the form of lobbying forces and political turmoil.

    • Renowned Scientist John Ioannidis remains optimistic about future discoveriesRenowned scientist John Ioannidis emphasizes the importance of staying curious and open-minded, looking forward to new discoveries and potential corrections.

      Renowned scientist John Ioannidis remains excited and optimistic about the future of science, viewing each new discovery as an opportunity to expand his knowledge and correct any potential errors. Ioannidis emphasizes the importance of remaining curious and open-minded, as there is still so much to learn. Regarding their personal connection, they expressed hope for another dinner together in 2021. The Drive podcast offers a membership program with exclusive content, including comprehensive podcast show notes, monthly AMA episodes, access to a private podcast feed, discounts on recommended products, and more. The podcast is for general informational purposes only and does not constitute medical advice. Conflicts of interest are disclosed on Ioannidis' website.

    Recent Episodes from The Peter Attia Drive

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter delves into two topics that have generated a lot of questions over the years: skin cancer and sunscreen. He begins by exploring the basics of UV radiation, discussing its effects on vitamin D conversion, photoaging, and its role in skin cancer. He examines various skin types, discussing their implications for sun exposure and vitamin D levels, as well as how to determine where you fall on the skin type scale. He then delves into the various types of skin cancer, with a particular emphasis on melanoma, exploring its complex relationship with UV exposure and other contributing risk factors. Additionally, he covers tanning beds, the importance of early skin cancer detection through regular skin checks, and the often confusing topic of sunscreen. He explains how sunscreen affects UV radiation and skin cancer risk, what SPF levels to choose, the differences between organic and mineral sunscreens, and what to consider when selecting the best sunscreen for your needs.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #61 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • The impact of UV radiation on the skin [2:00];
    • Understanding solar UV: from the electromagnetic spectrum to skin health [3:45];
    • The role of sunlight in vitamin D production [8:30];
    • Factors contributing to vitamin D deficiency: insufficient UV exposure, magnesium levels, and more [9:45];
    • Sun exposure needs for different skin types, and the limitations of current studies in defining vitamin D deficiency [12:45];
    • The acute and long-term effects of excessive UV exposure: sunburn, photoaging, and the increased risk of skin cancer [15:30];
    • Types of skin cancer and associations with UV exposure [17:45];
    • The complex relationship between melanoma and UV exposure [22:15];
    • Why UV exposure alone doesn’t necessarily explain the risk for melanoma [25:15];
    • Other risk factors for melanoma [29:15];
    • Tanning beds and skin cancer risk [34:45];
    • Balancing sun exposure: benefits and risks [38:15];
    • Tattoos and sun exposure [40:30];
    • The importance of regular skin checks, dermatologists, and emerging technologies showing promise for early detection of cancer [41:45];
    • Self-skin checks: what to look for [46:30];
    • Prevalence of skin cancer and the importance of early detection [49:30];
    • Summary of the major risk factors for melanoma [54:15];
    • The role of sunscreen in reducing skin cancer risk [55:45];
    • How sunscreen works, the differences between chemical and mineral sunscreens, an explanation of SPF, and more [58:30];
    • How to determine the appropriate sunscreen SPF to use based on the UV index [1:04:45];
    • Choosing the right sunscreen for your individual needs [1:07:00];
    • The impact of water and perspiration on sunscreen effectiveness [1:12:00];
    • Chemical vs. mineral sunscreens: safety concerns and recommendations [1:14:00];
    • Concerns about hormone effects from chemical sunscreens [1:19:15];
    • Sunscreen summary: skin types, key considerations, recommended brands, and more [1:23:15]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 01, 2024

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special episode, Peter addresses the common questions about starting or returning to an exercise routine over the age of 50. Individuals in this age group have frequently reached out with questions about whether it's too late to start exercising and often express concern over a lack of prior training, a fear of injury, or uncertainty about where to begin. Peter delves into the importance of fitness for older adults, examining all four pillars of exercise, and provides practical advice on how to start exercising safely, minimize injury risk, and maximize potential benefits. Although this conversation focuses on people in the “older” age category, it also applies to anyone of any age who is deconditioned and looking to ease into regular exercise.

    We discuss:

    • Key points about starting exercise as an older adult [2:45];
    • Why it’s never too late to begin exercising and incorporating the four pillars of exercise [5:45];
    • The gradual, then sharp, decline in muscle mass and activity level that occur with age [10:00];
    • The decline of VO2 max that occurs with age [15:30];
    • Starting a training program: exercise variability, movement quality, realistic goals, and more [18:30];
    • Improving aerobic capacity: the malleability of the system, the importance of consistency, and setting long-term fitness goals [25:15];
    • Starting cardio training: base building, starting with low volume, and zone 2 training [30:45];
    • The critical role of VO2 max in longevity [36:45];
    • How to introduce VO2 max training to older or deconditioned individuals [46:15];
    • Options for performing zone 2 and VO2 max training [53:45];
    • The ability to make gains in strength and muscle mass as we age [57:00];
    • How to implement strength training for older individuals [1:01:00];
    • Advice for avoiding injury when strength training [1:07:30];
    • Risk of falls: the devastating consequences and the factors that increase fall risk [1:12:15];
    • Mitigating fall risk: the importance of foot and lower leg strength, ankle mobility, and balance [1:19:45];
    • Improving bone mineral density through resistance training [1:24:30];
    • The importance of protein in stimulating muscle protein synthesis, especially in older adults [1:31:00];
    • Parting advice from Peter [1:34:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 24, 2024

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter provides insights on a broad range of important topics. He delves into the prevention of cognitive decline, the link between cardiovascular disease and Alzheimer's disease, and methods to lower blood glucose, insulin, and apoB. He also addresses nutrition-related queries, exploring the impact of dietary habits on weight loss and longevity, how a person can identify the best diet for themselves, and common nutrition myths. Additional discussions include optimal blood pressure, daily step goals, the benefits of standing versus sitting desks, and much more.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #60 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Overview of topics and episode format [1:40];
    • Preventing cognitive decline [5:00];
    • How to lower blood glucose and insulin [13:30];
    • The relationship between lipids, CVD, and Alzheimer’s disease, and whether statins can increase the risk of neurodegenerative disorders and AD [23:15];
    • Reducing apoB levels through exercise and diet [31:45];
    • Pharmacological options for lowering apoB [38:00];
    • How nutrition impacts longevity via metabolic health, muscle mass, BMD and more [40:15];
    • How can someone determine the best diet for themselves? [43:45];
    • Nutrition myth: All weight loss is good [46:45];
    • Nutrition myth: Metabolic rates are dramatically different among individuals based on genetics [49:00];
    • Nutrition myth: Losing weight after a brief period of overeating is impossible [53:45];
    • Nutrition myth: GLP-1 agonists are a replacement for a healthy lifestyle [57:45];
    • Nutrition myth: There is a single best diet for weight loss [1:03:00];
    • Nutrition oversimplification: All calories are created equal [1:05:45];
    • Daily step goals [1:06:45];
    • The benefits of standing versus sitting throughout the day [1:10:45];
    • How to identify the most impactful and easiest-to-implement ways to improve your health [1:12:30];
    • The critical importance of emotional health [1:14:30];
    • Why supplements should be considered as supportive aids rather than primary solutions in one’s strategy to improve longevity [1:18:00];
    • Strategies for reducing high blood pressure [1:20:45];
    • Peter’s biggest frustrations with "mainstream health advice" [1:28:00];
    • Peter’s chaotic, yet cherished, morning routine [1:31:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 17, 2024

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Joel Jamieson is a conditioning expert who developed Morpheus to give people a smarter way to build their conditioning regimen and improve their recovery. In this episode, Joel dives deep into the world of heart rate variability (HRV), explaining its scientific foundation, how it measures the balance between the sympathetic and parasympathetic nervous systems, the various methods of measurement, and how it can guide healthier lifestyle choices and improved training performance. He explores the nuances of HRV calculation, the impact of aging on HRV, and the roles of genetics, exercise, and other lifestyle factors in this process. He also covers Morpheus, the innovative training tool that won Peter over after his initial skepticism, highlighting its practicality and effectiveness in guiding training and optimizing fitness outcomes.

    We discuss:

    • Heart rate variability (HRV): evolution, science, and practical applications of HRV in athletic training [4:00];
    • Methods of measuring HRV: EKG, wrist-based sensors, and more [11:30];
    • How HRV is calculated from the data [22:30];
    • The role of the autonomic nervous system (ANS) in regulating HRV [25:45];
    • The decline in HRV with age, and the mitigating effects of fitness and other lifestyle factors [33:30];
    • The role of genetics in HRV, the modifiability of HRV, and a comparison of VO2 max and HRV as predictors of mortality [37:00];
    • How aging affects HRV and sympathetic drive, and the importance of spontaneous movement and exercise in maintaining the body's adaptability [43:30];
    • How Morpheus measures HRV using RMSSD and normalizes it to a 100-point scale for easier interpretation [49:45];
    • The Morpheus system: development, integration with various metrics, and personalized daily training recommendations to optimize fitness and recovery [51:30];
    • The benefits of morning HRV readings for assessing daily readiness compared to overnight HRV measurements [1:03:00];
    • Why Morpheus recommends using a chest strap rather than an arm band [1:10:00];
    • The impact of consistent exercise, stress, alcohol, and other lifestyle factors on HRV [1:11:15];
    • Optimizing zone 2 training with Morpheus [1:18:15];
    • Using heart rate recovery (HRR) as an indicator of athletic conditioning and the balance between aerobic and anaerobic systems [1:22:45];
    • The importance of tracking HRV trends over time rather than focusing on data from a given day [1:29:00];
    • Effect of GLP-1 agonists on heart rate and HRV [1:34:45];
    • Where HRV belongs in the hierarchy of health metrics [1:42:00];
    • Parting thoughts [1:46:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 10, 2024

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this quarterly podcast summary (QPS) episode, Peter introduces a new format aimed at summarizing his biggest takeaways from the last three months of guest interviews on the podcast. Peter shares key insights from each episode, covering diverse topics such as protein and muscle building with Luc van Loon, toe strength with Courtney Conley, VO2 max with Olav Aleksander Bu, liquid biopsies for cancer with Alex Aravanis, gut health and probiotics with Colleen Cutcliffe, and road safety with Mark Rosekind. Additionally, Peter shares any personal behavioral adjustments or modifications to his patient care practices that have arisen from these engaging discussions.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the episode #304 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • How Peter keeps track of his takeaways from each podcast episode [5:15];
    • Luc van Loon episode: fat utilization, muscle protein synthesis, dietary protein, aging and inactivity, and more [8:45];
    • Behavioral changes that have come about from the conversation with Luc van Loon [23:45];
    • Courtney Conley episode: importance of toe strength and the impact of dedicated foot training [26:45];
    • Olav Aleksander Bu episode: the importance of VO2 max for lifespan, and the practicalities of measuring and improving VO2 max [36:45];
    • Behavioral changes that have come about from the conversation with Olav [56:00];
    • Alex Aravanis episode: liquid biopsies for cancer detection [1:01:30];
    • Colleen Cutcliffe episode: the importance of gut bacteria balance, and the potential therapeutic uses of probiotics, particularly Akkermansia [1:16:45];
    • Mark Rosekind: the significant issue of road fatalities and injuries, their causes, and practical safety measures to reduce risks [1:27:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 03, 2024

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Dena Dubal is a physician-scientist and professor of neurology at UCSF whose work focuses on mechanisms of longevity and brain resilience. In this episode, Dena delves into the intricacies of the longevity factor klotho: its formation and distribution in the body, the factors such as stress and exercise that impact its levels, and its profound impact on cognitive function and overall brain health. Dena shares insights from exciting research in animal models showing the potential of klotho in treating neurodegenerative diseases as well as its broader implications for organ health and disease prevention. She concludes with an optimistic outlook for future research in humans and the potential of klotho for the prevention and treatment of Alzheimer’s disease.

    Disclosure: Peter is an investor in Jocasta Neuroscience, a company working to develop klotho as a therapy for people with Alzheimer’s disease.

    We discuss:

    • Dena’s fascination with aging and how she came to study klotho [3:30];
    • Biological properties of klotho: production, regulation, decline with age, and factors influencing its levels [11:45];
    • Potential benefits of klotho on brain health [22:00];
    • The relationship between soluble klotho protein, platelet factors, and cognitive enhancement [33:45];
    • The role of platelet factor 4 (PF4) and it’s interaction with GluN2B in mediating cognitive enhancement [46:45];
    • Benefits of klotho observed in a mouse model of Parkinson’s disease [55:45];
    • Benefits of klotho observed in a mouse model of Alzheimer’s disease [1:03:00];
    • Promising results of klotho in primate models, and the importance of finding an appropriate therapeutic dose before moving to human trials [1:08:00];
    • Speculating why a single klotho injection has such long-lasting effects [1:25:30];
    • Potential cognitive benefits of klotho in humans, the impact of the KL-VS genetic variant on klotho levels, and the need for human trials to confirm these effects [1:27:45];
    • The interaction between the KL-VS genetic variant and APOE4 and how it impacts risk of Alzheimer’s disease [1:34:45];
    • The significance of klotho levels: studies linking lower levels to increased mortality and the broader implications for organ health and disease prevention [1:47:15];
    • Measuring klotho levels and determining an individual’s KL-VS status [1:52:15];
    • The promising potential of klotho for Alzheimer’s disease treatment, and the importance of philanthropy for funding research [1:58:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 27, 2024

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Julia Wattacheril is a physician scientist and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. In this episode, Julia delves deep into the complex world of liver health, beginning with a foundational overview of liver physiology. She provides an in-depth look at how alcohol impacts liver function, breaking down the metabolism of ethanol and its detrimental effects. Julia then shifts the focus to understanding liver function tests and optimal enzyme levels, providing a detailed explanation of AST and ALT and elucidating why fluctuations in these levels may or may not be concerning. She provides a primer on the four major stages of liver disease, discussing risk and emphasizing the importance of early diagnosis. Julia highlights the role of liver disease in increasing the risk of cancer and cardiovascular disease and covers in detail the various strategies for diagnosing, treating, and preventing the progression of liver disease.

    We discuss:

    • Julia’s training, the importance of liver health, and the challenges and innovations of hepatology [3:15];
    • The complex and crucial functionality of the liver, its four most essential functions, and more [8:45];
    • Liver injuries: historical and evolving understanding of causal factors, and the progression to liver diseases and cancer [13:15];
    • How the liver metabolizes nutrients and what happens in the presence of excess calories or alcohol [24:45];
    • Methods of diagnosing liver disease and how insights guide treatment and management strategies [33:30];
    • The poisonous nature of ethanol to the liver [40:30];
    • Varied responses to alcohol, damaging effects of alcohol beyond the liver, and the process of advising patients on their alcohol consumption [47:15];
    • Understanding liver enzymes AST and ALT—interpreting levels, lifestyle factors that affect them, and diagnostic approaches [58:30];
    • Interpreting liver function tests for fatty liver disease, and the challenges of diagnosing liver pathologies, particularly in children versus adults [1:13:15];
    • Comprehensive liver health assessments via imaging and various diagnostic tools to prevent overlooking potential liver pathologies [1:18:45];
    • Potential impact of recreational drugs, statins, and other medications on liver function test results [1:26:45];
    • Shifting nomenclature from NAFLD to MASLD to reflect accuracy in the underlying pathophysiology and understanding of liver diseases [1:30:30];
    • Pathophysiology of MASLD, the need for proactive screening, and the significance of liver fat percentage as an indicator of metabolic health [1:36:30];
    • The importance of screening for rare conditions alongside common metabolic diseases associated with fatty liver accumulation [1:42:45];
    • Practical strategies for managing MAFLD [1:45:30];
    • The impact of fructose consumption on liver health and the challenges of disentangling its effects from other factors like obesity and insulin resistance [1:52:45];
    • The potential of GLP-1 agonists for the treatment of MASLD [1:57:45];
    • How the four stages of liver disease have evolved [2:00:30];
    • Increased cancer and heart disease risk associated with early-stage MAFLD [2:05:15];
    • Emerging drugs and therapies for addressing fat accumulation and fibrosis related to MAFLD [2:12:15];
    • Peter’s major takeaways [2:18:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 20, 2024

    #301 - AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it

    #301 - AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter delves into the often misunderstood concept of inflammation. He first defines inflammation and differentiates between acute inflammation and chronic inflammation, the latter of which is linked to aging and a plethora of age-related diseases. Peter breaks down the intricate relationship between chronic inflammation, obesity, and metabolic health, and highlights the signs that might suggest someone may be suffering from chronic inflammation. From there, the conversation centers on actionable advice and practical steps one can take to manage and minimize chronic inflammation. He explores how diet plays a crucial role, including the potential benefits of elimination diets, and he examines the impact of lifestyle factors such as exercise, sleep, and stress management. Additionally, he discusses the relevance of food inflammatory tests and concludes by examining the potential benefits and drawbacks of drugs and supplements in managing inflammation.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #59 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Defining inflammation (and the cultural impact of Napoleon Dynamite) [1:45];
    • Acute vs chronic inflammation [8:00];
    • The connection between chronic inflammation, aging, and age-related diseases [11:00];
    • The impact of inflammation on metabolic health [18:30];
    • Understanding and diagnosing chronic inflammation: blood tests and other approaches, and challenges with measurement [20:00];
    • Factors that contribute to low-level chronic inflammation [28:00];
    • Minimizing inflammation through diet [29:45];
    • The important role of fiber for gut health and inflammation [33:45];
    • A closer look at the impact of trans fats and saturated fats on overall health [34:45];
    • Why Peter prefers dietary fiber from food sources over supplements [38:30];
    • Debunking “superfoods”: emphasizing proven methods over marketing claims for reducing inflammation [39:00];
    • Is there any value in over-the-counter food inflammatory tests? [42:30];
    • Food elimination diets: how they work, symptoms and markers to watch, challenges and limitations [45:15];
    • Identifying dietary triggers for gut-related symptoms through low-FODMAP diets like the “carnivore diet” [51:15];
    • Dairy: the complex role of dairy on inflammation and individual responses [55:00];
    • Wheat: the complexities and conflicting evidence around wheat's inflammatory effects [57:45];
    • How exercise influences inflammation [1:02:00];
    • How sleep quality and duration impacts inflammation [1:07:00];
    • The potential impact of chronic psychological stressors on inflammation [1:13:00];
    • The impact of oral health on inflammation and overall well-being [1:15:00];
    • The role of medications in managing chronic inflammation [1:18:15];
    • Supplements: evaluating the efficacy of various anti-inflammatory supplements [1:22:15];
    • Parting thoughts and takeaways [1:27:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 13, 2024

    #300 - Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?

    #300 - Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special edition celebrating 300 episodes of The Drive, Peter discusses a variety of popular topics and health interventions and classifies them based on their level of evidence and relevance using the following categories: proven, promising, fuzzy, noise, and nonsense. Peter first delves into the topic of geroprotective molecules, covering rapamycin, metformin, NAD and its precursors, and resveratrol. Next, he explores the significance of metrics like VO2 max and muscle mass, as well as emerging concepts like blood flow restriction and stem cells. The conversation extends to nutrition, addressing questions surrounding long-term fasting, sugar consumption, sugar substitutes, and the contentious role of red meat in cancer. Peter not only provides his current stance on each topic—most of which have been covered in great detail in the previous 300 episodes—but also reflects on how his opinion may have evolved over the years.

    We discuss:

    • Defining the categories of “proven, promising, fuzzy, noise, and nonsense” [3:15];
    • Rapamycin [9:30];
    • Metformin [17:00];
    • NAD and its precursors [24:30];
    • Resveratrol [32:45];
    • The importance of VO2 max, muscle mass, and muscular strength for lifespan [38:15];
    • Blood flow restriction (BFR) training [44:00];
    • Using stem cells to treat osteoarthritis or injury [51:30];
    • Fasting as a tool for longevity (and why Peter stopped his fasting protocol) [55:45];
    • The energy balance theory [1:06:30];
    • The idea that sugar is poison [1:12:00];
    • The idea that sugar substitutes are dangerous [1:22:15];
    • The debate on red meat and cancer [1:28:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    Special episode with Dax Shepard: F1 and the 30th anniversary of Ayrton Senna’s death

    Special episode with Dax Shepard: F1 and the 30th anniversary of Ayrton Senna’s death

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    This is a special episode of The Drive with Peter’s friend and fellow car enthusiast Dax Shepard. In this podcast, which commemorates the 30th anniversary of the death of Brazilian Formula One legend Ayrton Senna, Dax sits down with Peter to better understand what made Senna so special and why Peter remains an enormous fan. This conversation focuses on Senna’s life, the circumstances of his death, and his lasting impact and legacy on the sport of F1.

    We discuss:

    • Peter’s interest in motorsports began as a child [2:30];
    • The drama and dangers of F1 [6:00];
    • What made Senna special [13:00];
    • What Senna meant to Brazilians [24:00];
    • The cause of the fatal crash [28:15];
    • Why Peter is obsessed with Senna [40:30];
    • Being the best versus having the best record [43:30];
    • Senna’s unique driving style and incredible intuition about automotive engineering [46:30];
    • Back to the day of the dreadful race [53:00];
    • What Peter believes caused the crash [1:02:45];
    • Views on dying young, in the prime of life [1:13:00];
    • Senna lives on in his foundation and in safety changes adopted by F1 [1:21:00];
    • Statistics aren’t enough for fandom, and why people like who they do [1:24:15];
    • The biggest difference between F1 today and F1 in the 80s [1:28:30];
    • Senna’s driving superpower [1:30:30];
    • The fastest drivers currently in F1 [1:38:30];
    • Current F1 obsessions [1:45:00];
    • How hard it is to do what the top F1 drivers do [1:50:15];
    • Dax’s love of motorcycles and his AMG E63 station wagon [1:52:15];
    • Awesome Senna mementos from Etsy [2:01:15];
    • What makes specialists interesting, and Max’s devotion to F1 [2:10:15];
    • What Senna might have done if he had not died that day [2:14:00];
    • Michael Schumacher and Max Verstappen are also top F1 drivers [2:17:30];
    • Interlagos in Sao Paulo Brazil is always an incredible experience [2:18:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    Related Episodes

    Toni Townes-Whitley (Microsoft) - The Ethics of Innovation

    Toni Townes-Whitley (Microsoft) - The Ethics of Innovation
    How often do entrepreneurs and corporate leaders think about issues like fairness, accessibility or unseen biases in the technologies they invent and advance? That’s the challenge for companies leading the digital transformation that’s disrupting every aspect of society, says Toni Townes-Whitley, Corporate Vice President of Worldwide Public Sector and Industry at Microsoft, in this talk about innovating strategically and responsibly.

    Responsibility: Responsible AI in action

    Responsibility: Responsible AI in action

    At Microsoft we believe AI solutions built responsibly not only ensures inclusion, fairness and transparency, it empowers you to create better products and experiences. In this episode you’ll hear from the experts inside and outside of Microsoft share learnings from their own experiences to help you innovate responsibly  as you develop your own AI systems.

    Click here for transcript of this episode.

    Microsoft's AI Business School

    David Carmona, Microsoft | LinkedIn [host]

    Guests:

    Nick McQuire, CCS Insight | LinkedIn

    Natasha Crampton, Microsoft | LinkedIn

    Sarah Bird, Microsoft, LinkedIn

    E37: NYC rejects far-left mayoral candidates, new developments in lab leak theory, Apple's App Store breakup potential & more

    E37: NYC rejects far-left mayoral candidates, new developments in lab leak theory, Apple's App Store breakup potential & more

    Follow the besties:

    https://twitter.com/chamath

    https://linktr.ee/calacanis

    https://twitter.com/DavidSacks

    https://twitter.com/friedberg

    Follow the pod:

    https://twitter.com/theallinpod

    https://linktr.ee/allinpodcast

    Intro Music Credit:

    https://rb.gy/tppkzl

    https://twitter.com/yung_spielburg

    Referenced in the show:

    NYT - N.Y.C. Mayoral Race Highlights: Adams Leads in Early Results Over Wiley and Garcia

    https://www.nytimes.com/live/2021/06/22/nyregion/nyc-primary-election

    Vanity Fair - Eric Adams interview

    https://www.vanityfair.com/news/2021/06/eric-adams-nyc-mayor-interview

    NY Daily News - ‘We don’t want fancy candidates’: Eric Adams declares himself ‘face of the new Democratic Party’

    https://www.nydailynews.com/news/politics/nyc-elections-2021/ny-eric-adams-democratic-party-nyc-mayoral-race-20210624-oemlj42abzc7jnime4tjfddfhm-story.html

    Jesse Bloom COVID origin research paper

    https://www.biorxiv.org/content/10.1101/2021.06.18.449051v1

    Destined for War: Can America and China Escape Thucydides’s Trap? by Graham Allison

    https://rb.gy/7vj8ks

    Apple says third-party app stores would leave iPhone users vulnerable to scammers

    https://fortune.com/2021/06/23/apple-iphone-third-party-app-store-users

    The Pull Request - Bad Apple* by Antonio Garcia Martinez

    https://www.thepullrequest.com/p/bad-apple

    Show Notes:

    0:00 Besties hash out a new format & the purpose of the podcast

    14:31 NYC rejects far-left candidates in mayoral primary; importance of crime, homelessness & drug abuse in elections

    29:29 New developments in the Wuhan lab leak theory, ramifications for our relationship with China

    54:07 Congress turns the heat on up big tech, Apple's App Store monopoly in trouble

    1:09:25 Antonio Garcia Martinez's first Substack article on Apple